StamlerJ. High blood pressure in the United States: An overview of the problem and the challenge. In: National Conference on High Blood Pressure Education: Report of Proceedings. Rockville, MD: US Department of Health, Education and Welfare, Public Health Service, National Institutes of Health; DHEW publication (NIH) 73–486; 1973: 11–66.
2.
PerryLM. Recommendations for a national high blood pressure program data base for effective antihypertensive therapy, report of Task Force I. DHEW publication No. (NTH) 75–593. Bethesda, MD: US Department of Health, Education, and Welfare, 1973.
3.
Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med1993; 153: 154–83.
4.
National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med1993; 153: 186–208.
HerbertPRMoserMMayerJGlynnRJHennekensCH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med1993; 153: 578–81.
7.
SharmaAMSchorrUDistlerA. Insulin resistance in young salt-sensitive normotensive subjects. Hypertension1993; 21: 273–9.
8.
SharmaAMRulandKSpiesKPDistlerA. Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hyertens1991; 9: 329–35.
9.
DenkerPSPollockVE. Fasting serum insulin levels in essential hypertension. A meta-analysis. Arch Intern Med1992; 152: 1649–51.
10.
ReavenGM. Role of insulin resistance in human disease. Diabetes1988; 37: 1595–607.
11.
KaplanNM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med1989; 149: 1514–20.
12.
The Treatment of Mild Hypertension Research Group. The treatment of mild hypertension study. Arch Intern Med1991; 151: 1413–23.